Genetic and epigenetic mechanisms in the development of congenital heart diseases

Yue Wu1, Xiaosi Jin2, Yuhao Zhang3

  • 1Department of Genetic and Metabolic Diseases, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.

Insights

Congenital heart disease (CHD) involves complex genetic and epigenetic factors. Understanding these mechanisms is key to improving diagnosis and reducing childhood mortality from these common birth defects.

Area of Science:

  • Cardiovascular Research
  • Developmental Biology
  • Genetics and Epigenetics

Background:

  • Congenital heart disease (CHD) is the most prevalent birth defect, causing significant global morbidity and mortality.
  • The complex pathogenesis of CHD hinders its classification and understanding.
  • Molecular medicine has identified genetic links, but comprehensive reviews on genetic and epigenetic mechanisms are scarce.

Purpose of the Study:

  • To comprehensively review the genetic and epigenetic factors contributing to CHD pathogenesis.
  • To elucidate the intricate interplay between genetic and epigenetic mechanisms in CHD development.
  • To provide a summative knowledge base for improved CHD diagnosis and treatment.

Main Methods:

  • Review of current literature on CHD etiology.
  • Detailed summary of genetic factors including chromosome abnormalities and gene mutations.
  • Detailed summary of epigenetic factors such as DNA methylation, histone modifications, and non-coding RNAs.

Main Results:

  • Genetic factors like chromosome abnormalities and gene mutations play a role in CHD.
  • Epigenetic factors including DNA methylation, histone modifications, and non-coding RNAs are crucial modulators.
  • The interaction between genetic and epigenetic factors is integral to CHD pathogenesis.

Conclusions:

  • Genetic and epigenetic factors are critical triggers in the pathogenesis of CHD.
  • A deeper understanding of these mechanisms is essential for reducing CHD morbidity and mortality.
  • This review consolidates knowledge to aid future diagnostic and therapeutic strategies for CHD.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
31
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
1.1K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.3K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
41
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
260